2022 Q3 Form 10-Q Financial Statement

#000121390022052249 Filed on August 30, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $347.2K $344.2K $309.6K
YoY Change 135.67% 19.18%
Cost Of Revenue $65.02K $68.68K $68.18K
YoY Change 41.35% 0.06%
Gross Profit $282.1K $275.5K $241.5K
YoY Change 178.49% 25.14%
Gross Profit Margin 81.27% 80.05% 77.98%
Selling, General & Admin $2.651M $2.747M
YoY Change -12.81% 39.26%
% of Gross Profit 939.77% 997.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$1.950K $202.4K $99.45K
YoY Change -657.14%
% of Gross Profit -0.69% 73.46% 41.19%
Operating Expenses $2.651M $2.747M $3.773M
YoY Change -12.81% 94.21%
Operating Profit -$2.369M -$2.472M -$3.532M
YoY Change -19.41% 106.94%
Interest Expense $104.3K $68.17K $50.56K
YoY Change -226.66% 219.35%
% of Operating Profit
Other Income/Expense, Net -$721.0K -$428.6K -$335.6K
YoY Change 160.04% 230.13%
Pretax Income -$3.090M -$2.900M -$3.867M
YoY Change -6.34% 67.82%
Income Tax $0.00 $889.6K -$223.0K
% Of Pretax Income
Net Earnings -$3.090M -$3.790M -$3.644M
YoY Change 13128.97% 186.19% 793.44%
Net Earnings / Revenue -890.16% -1101.24% -1176.91%
Basic Earnings Per Share -$0.08 -$0.10 -$0.10
Diluted Earnings Per Share -$0.10 -$0.10 -$0.10
COMMON SHARES
Basic Shares Outstanding 40.29M shares 38.97M shares 36.21M shares
Diluted Shares Outstanding 40.17M shares 38.97M shares 36.21M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.078M $1.654M
YoY Change -45.16%
Cash & Equivalents $680.9K $1.212M $345.1K
Short-Term Investments $396.9K $442.3K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $602.9K $609.7K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.681M $2.264M
YoY Change -41.73%
LONG-TERM ASSETS
Property, Plant & Equipment $30.32K $9.572K
YoY Change 543.74%
Goodwill $3.636M $3.636M
YoY Change
Intangibles $1.703M $1.700M
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $5.725M $5.717M
YoY Change 21.13%
TOTAL ASSETS
Total Short-Term Assets $1.681M $2.264M
Total Long-Term Assets $5.725M $5.717M
Total Assets $7.406M $7.981M
YoY Change -2.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.588M $1.561M
YoY Change 62.75%
Accrued Expenses $65.22K $63.43K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $142.6K $169.8K
YoY Change -19.42%
Long-Term Debt Due $5.300K $5.300K
YoY Change -30.81%
Total Short-Term Liabilities $1.801M $1.799M
YoY Change 55.22%
LONG-TERM LIABILITIES
Long-Term Debt $2.476M $2.187M
YoY Change 354.58%
Other Long-Term Liabilities $300.6K $317.6K
YoY Change
Total Long-Term Liabilities $2.777M $2.504M
YoY Change 409.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.801M $1.799M
Total Long-Term Liabilities $2.777M $2.504M
Total Liabilities $4.578M $4.304M
YoY Change 254.38%
SHAREHOLDERS EQUITY
Retained Earnings -$18.83M -$15.74M
YoY Change
Common Stock $40.29K $38.98K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.829M $3.678M
YoY Change
Total Liabilities & Shareholders Equity $7.406M $7.981M
YoY Change -2.7%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.090M -$3.790M -$3.644M
YoY Change 13128.97% 186.19% 793.44%
Depreciation, Depletion And Amortization -$1.950K $202.4K $99.45K
YoY Change -657.14%
Cash From Operating Activities -$880.1K -$42.46K -$767.1K
YoY Change -58.29%
INVESTING ACTIVITIES
Capital Expenditures -$21.88K -$2.440K
YoY Change 332.41%
Acquisitions -$9.000K
YoY Change
Other Investing Activities $0.00 $1.777M
YoY Change -100.0%
Cash From Investing Activities -$21.88K $1.774M $856.2K
YoY Change -97.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 371.2K -956.8K -$4.851K
YoY Change -88.61%
NET CHANGE
Cash From Operating Activities -880.1K -42.46K -$767.1K
Cash From Investing Activities -21.88K 1.774M $856.2K
Cash From Financing Activities 371.2K -956.8K -$4.851K
Net Change In Cash -530.8K 775.1K $84.23K
YoY Change -402.11%
FREE CASH FLOW
Cash From Operating Activities -$880.1K -$42.46K -$767.1K
Capital Expenditures -$21.88K -$2.440K
Free Cash Flow -$858.2K -$40.02K
YoY Change -59.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
250000 shares
ohcs Stock Issued Business Acquisition
StockIssuedBusinessAcquisition
usd
ohcs Stock Issued Business Acquisition
StockIssuedBusinessAcquisition
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
ohcs Sharebased Compensation Arrangement By Weighted Average Remaining Term Options Cancelled
SharebasedCompensationArrangementByWeightedAverageRemainingTermOptionsCancelled
CY2021Q2 us-gaap Depreciation
Depreciation
usd
CY2021 ohcs Website
Website
usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
196121 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-261849
dei Entity Registrant Name
EntityRegistrantName
OPTIMUS HEALTHCARE SERVICES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0181535
dei Entity Address Address Line1
EntityAddressAddressLine1
1400 Old Country Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 306
dei Entity Address City Or Town
EntityAddressCityOrTown
Westbury
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11590
dei City Area Code
CityAreaCode
(516)
dei Local Phone Number
LocalPhoneNumber
806-4201
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40286598 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1211651 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
260838 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
609670 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
474638 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11290 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10945 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
430961 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1327440 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2263572 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2073861 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
372214 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
318717 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9572 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4516 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1699722 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1899748 usd
CY2022Q2 us-gaap Goodwill
Goodwill
3635845 usd
CY2021Q4 us-gaap Goodwill
Goodwill
2820345 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
666616 usd
CY2022Q2 us-gaap Assets
Assets
7980925 usd
CY2021Q4 us-gaap Assets
Assets
7783803 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1560714 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1190431 usd
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
144011 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
150079 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
617 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
617 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
25200 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
25200 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
5304 usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
5304 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
63429 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45224 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1799275 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1416855 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
317563 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
279968 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2177324 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
663014 usd
CY2022Q2 us-gaap Program Rights Obligations Noncurrent
ProgramRightsObligationsNoncurrent
9437 usd
CY2021Q4 us-gaap Program Rights Obligations Noncurrent
ProgramRightsObligationsNoncurrent
11482 usd
CY2022Q2 us-gaap Liabilities
Liabilities
4303599 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2371319 usd
CY2022Q2 ohcs Preferred Stock Value1
PreferredStockValue1
2 usd
CY2021Q4 ohcs Preferred Stock Value1
PreferredStockValue1
10001 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
8106 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
8106 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
130000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
130000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38974598 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38974598 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26225974 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26225974 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
38975 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
26226 usd
CY2022Q2 us-gaap Common Unit Issuance Value
CommonUnitIssuanceValue
575 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19372322 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13676762 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15741736 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8307686 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3678244 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5413409 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-918 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-925 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3677326 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5412484 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7980925 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7783803 usd
CY2022Q2 us-gaap Revenues
Revenues
344157 usd
CY2021Q2 us-gaap Revenues
Revenues
288765 usd
us-gaap Revenues
Revenues
653786 usd
us-gaap Revenues
Revenues
474926 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
68676 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
68633 usd
us-gaap Cost Of Revenue
CostOfRevenue
136853 usd
us-gaap Cost Of Revenue
CostOfRevenue
105281 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
275481 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
220132 usd
us-gaap Gross Profit
GrossProfit
516933 usd
us-gaap Gross Profit
GrossProfit
369645 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1405192 usd
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
459313 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3886702 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
459313 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
584775 usd
CY2021Q2 us-gaap Other Expenses
OtherExpenses
348673 usd
us-gaap Other Expenses
OtherExpenses
1042311 usd
us-gaap Other Expenses
OtherExpenses
621098 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
585550 usd
CY2021 ohcs Transfersto From The Noncontrolling Interest
TransferstoFromTheNoncontrollingInterest
usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1233000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
239150 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
171684 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
410458 usd
us-gaap Professional Fees
ProfessionalFees
358151 usd
us-gaap Professional Fees
ProfessionalFees
649876 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2747201 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1414565 usd
us-gaap Operating Expenses
OperatingExpenses
6520164 usd
us-gaap Operating Expenses
OperatingExpenses
1969437 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2471720 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1194433 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6003231 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1599792 usd
CY2022Q2 ohcs Amortization Of Financing Cost
AmortizationOfFinancingCost
277761 usd
CY2021Q2 ohcs Amortization Of Financing Cost
AmortizationOfFinancingCost
108493 usd
ohcs Amortization Of Financing Cost
AmortizationOfFinancingCost
548993 usd
ohcs Amortization Of Financing Cost
AmortizationOfFinancingCost
108493 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
68165 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
21345 usd
us-gaap Interest Expense
InterestExpense
118724 usd
us-gaap Interest Expense
InterestExpense
23854 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-82714 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-96479 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-428640 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-129838 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-764196 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-132347 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
889625 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
666616 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
51 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
65919 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
7 usd
CY2022Q2 ohcs Net Income Loss Available To Common Stockholder Basic
NetIncomeLossAvailableToCommonStockholderBasic
-3790036 usd
CY2021Q2 ohcs Net Income Loss Available To Common Stockholder Basic
NetIncomeLossAvailableToCommonStockholderBasic
-1390190 usd
ohcs Net Income Loss Available To Common Stockholder Basic
NetIncomeLossAvailableToCommonStockholderBasic
-7434050 usd
ohcs Net Income Loss Available To Common Stockholder Basic
NetIncomeLossAvailableToCommonStockholderBasic
-1732139 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-3789985 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1324271 usd
us-gaap Profit Loss
ProfitLoss
-7434043 usd
us-gaap Profit Loss
ProfitLoss
-1732139 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38974598 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21038115 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37538640 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16993671 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5412484 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
467500 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2481510 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-3644058 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4717436 usd
CY2022Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
375000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
111847 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
857835 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1405193 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-3789985 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3677326 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
272129 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4560002 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-407868 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4424263 usd
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
610000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
459313 usd
CY2021Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
88691 usd
CY2021Q2 ohcs Fair Value Of Beneficial Conversion Feature
FairValueOfBeneficialConversionFeature
982547 usd
CY2021Q2 ohcs Common Stock Issued In Connection With Debt Financing
CommonStockIssuedInConnectionWithDebtFinancing
928762 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1324271 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6169305 usd
us-gaap Net Income Loss
NetIncomeLoss
-7434043 usd
us-gaap Net Income Loss
NetIncomeLoss
-1732139 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
202716 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
148 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3886703 usd
us-gaap Share Based Compensation
ShareBasedCompensation
459313 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-96479 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
548993 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
108493 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2303 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
666616 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
135033 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5802 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
345 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5404 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13033 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-151480 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2152578 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1304459 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-9000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-248122 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2203666 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1403666 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
7496 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
5087 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
801504 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
243035 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
375000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
610000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1935000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
148975 usd
us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
2045 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6068 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
41154 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2301887 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2717821 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
950813 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1656397 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
260838 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1033513 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1211651 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2689910 usd
us-gaap Interest Paid Net
InterestPaidNet
99000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. Nature of operations</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Optimus Healthcare Services, Inc. (formerly Between Dandelions, Inc., “Optimus”, “Company”) was initially organized under the laws of Florida on February 26, 1990, as Phoenix Management Associates, Inc. Over the ensuing years, the Company made a series of amendments to its Articles of Incorporation relating to authorization of various series of Preferred Shares and made a series of name changes. The current name of Optimus Healthcare Services, Inc. became effective with the State of Florida on January 24, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is dedicated to: (1) improving patient/physician interactions and outcomes through the acquisition and deployment of telehealth and compliance technologies (TACT); (2) advancing access to clinical trial research; and (3) improving and simplifying access to vaccines and pharmaceutical products. Currently the Company provides these services through its portfolio companies, AdhereRx Corporation (d/b/a PainScript), Clinical Research Alliance, Inc. (CRA), and Worker’s Health Rx (d/b/a Vaccinations Rx).</p>
CY2021Q4 ohcs Office Lease
OfficeLease
371832 usd
CY2022Q2 ohcs Equipment Lease
EquipmentLease
5611 usd
CY2021Q4 ohcs Equipment Lease
EquipmentLease
5611 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
90216 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
58726 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant assumptions and estimates relate to the valuation of equity issued for services, valuation of equity associated with convertible debt, the valuation of derivative liabilities, and the valuation of deferred tax assets. Actual results could differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35pt"> </p>
us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35pt"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, “<i>Revenue from contracts with customers,”</i> (Topic 606). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company’s main revenue stream is from services. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time, typically upon delivery.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify">For services performed by CRA, the Company’s performance obligations are generally met at the point in time the services are rendered.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify">Adhere Rx, Inc. provides software services primarily to physicians and physician groups through a cloud software as a service (SaaS) platform through which the physicians and physician groups will be billed on a periodic basis for the services. Adhere Rx, Inc. will typically meet its performance obligations over a period of time. Revenues will be recognized ratable over the related contractual term of the service.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify"> </p>
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
372214 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
318717 usd
CY2021Q4 ohcs Office Lease Liability
OfficeLeaseLiability
321214 usd
CY2022Q2 ohcs Equipment Lease Liability
EquipmentLeaseLiability
3038 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
296250 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
55000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
505000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
378750 shares
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
3886702 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
459313 usd
us-gaap Advertising Expense
AdvertisingExpense
17150 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2022Q2 ohcs Office Lease Liability
OfficeLeaseLiability
377954 usd
us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.50 pure
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
71323 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
88269 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
73223 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
49677 usd
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
853870 usd
us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
179 usd
ohcs Interest Rate Of Lease
InterestRateOfLease
0.075 pure
CY2022Q2 ohcs Office Lease
OfficeLease
456819 usd
CY2021Q4 ohcs Equipment Lease Liability
EquipmentLeaseLiability
3978 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
63429 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45224 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
317563 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
279968 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44661 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
69094 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
91055 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
69834 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
91335 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
69477 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
93837 usd
CY2021 ohcs Net Transfers Fromto Noncontrolling Interest
NetTransfersFromtoNoncontrollingInterest
usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
49677 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
458834 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
402628 usd
CY2022Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
77842 usd
CY2021Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
77436 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
380992 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
325192 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1211651 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
260838 usd
CY2022Q2 us-gaap Capital Units Net Amount
CapitalUnitsNetAmount
464297 usd
CY2021Q4 us-gaap Capital Units Net Amount
CapitalUnitsNetAmount
657006 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
7434043 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1732139 usd
ohcs Going Concern Term
GoingConcernTerm
P1Y
ohcs Gross Unrealized Gain
GrossUnrealizedGain
usd
CY2020Q4 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
1 pure
CY2020Q4 ohcs Business Acquisition Percentage Of Voting Interest Acquired
BusinessAcquisitionPercentageOfVotingInterestAcquired
0.73 pure
CY2021Q3 us-gaap Memberships In Exchanges Owned
MembershipsInExchangesOwned
425000 usd
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
1
us-gaap Common Stock Voting Rights
CommonStockVotingRights
1.25
ohcs Website
Website
3000 usd
CY2022Q2 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
329523 usd
CY2021Q4 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
126497 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1699722 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1899748 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
202026 usd
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21060 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
11555 usd
CY2022Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
9649 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3904 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30709 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15459 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21137 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10943 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9572 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4516 usd
us-gaap Depreciation
Depreciation
690 usd
us-gaap Development Costs
DevelopmentCosts
2026245 usd
CY2021 us-gaap Development Costs
DevelopmentCosts
2026245 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0 usd
CY2022Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
569948 usd
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1350000 usd
ohcs Gross Unrealized Loss
GrossUnrealizedLoss
-138987 usd
CY2021 ohcs Gross Unrealized Loss
GrossUnrealizedLoss
-22560 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
430961 usd
CY2021 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
1327440 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
96479 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
42509 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
144011 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
150079 usd
CY2022Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
250000 usd
us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0164 pure
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
6068 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
617 usd
CY2021Q2 us-gaap Notes Payable
NotesPayable
617 usd
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
9437 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
617 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
617 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
25200 usd
CY2011Q1 ohcs Issued1
Issued1
10000 usd
CY2022Q2 ohcs No Coupon Due On Demand Issued One
NoCouponDueOnDemandIssuedOne
10000 usd
CY2021Q4 ohcs No Coupon Due On Demand Issued One
NoCouponDueOnDemandIssuedOne
10000 usd
CY2016Q4 ohcs Issued2
Issued2
15000 usd
CY2022Q2 ohcs No Coupon Due On Demand Issued Two
NoCouponDueOnDemandIssuedTwo
15000 usd
CY2021Q4 ohcs No Coupon Due On Demand Issued Two
NoCouponDueOnDemandIssuedTwo
15000 usd
CY2020Q4 ohcs Issued3
Issued3
10100 usd
CY2022Q2 ohcs No Coupon Due On Demand Issued Three
NoCouponDueOnDemandIssuedThree
200 usd
CY2021Q4 ohcs No Coupon Due On Demand Issued Three
NoCouponDueOnDemandIssuedThree
200 usd
CY2022Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
25200 usd
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
25200 usd
CY2020Q2 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
145683 usd
CY2021Q1 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
148975 usd
CY2022Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
126546 usd
CY2020Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
126546 usd
us-gaap Loans Receivable Description Of Variable Rate Basis
LoansReceivableDescriptionOfVariableRateBasis
The unforgiven portion of the PPP loan totaling $19,137 is payable over five years at an interest rate of 1%, with a deferral of payments for the first twelve months.
CY2022Q2 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
5304 usd
CY2021Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
148975 usd
us-gaap Loan Portfolio Expense
LoanPortfolioExpense
2045 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2177324 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
663014 usd
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2200000 usd
CY2021Q2 us-gaap Debt Instrument Description
DebtInstrumentDescription
the Company entered into a securities purchase agreement with certain institutional investors (collectively, the “May 2021 Investors”) pursuant to which the Company issued convertible notes in an aggregate principal amount of $2,200,000 for an aggregate purchase price of $2 million (collectively, the “May 2021 Notes”). In connection with the issuance of the May 2021 Notes, the Company issued to the May 2021 Investors warrants to purchase an aggregate of 165,000 shares of common stock (collectively, the “Warrants”) and 1,727,859 shares of common stock. The May 2021 Notes accrue interest at a rate of 9% per annum, subject to increase to 20% per annum upon and during the occurrence of an event of default. Interest is payable in cash on a quarterly basis. The May 2021 Notes are convertible at any time, at the holder’s option, into shares of the Company’s common stock at a conversion price of $1.00 per share, subject to certain beneficial ownership limitations (with a maximum ownership limit of 9.99%). The conversion price is also subject to adjustment due to certain events, including stock dividends and stock splits.Each Warrant is exercisable for a period of five years from the date of issuance at an initial exercise price of $1.25 per share, subject to certain beneficial ownership limitations (with a maximum ownership limit of 9.99%).
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2200000 usd
CY2022Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2200000 usd
CY2022Q2 ohcs Aggregate Purchase Price
AggregatePurchasePrice
2000000 usd
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1
CY2022Q2 ohcs Equity Method Investments Ownership Percentages
EquityMethodInvestmentsOwnershipPercentages
0.0999 pure
us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
Each Warrant is exercisable for a period of five years from the date of issuance at an initial exercise price of $1.25 per share, subject to certain beneficial ownership limitations (with a maximum ownership limit of 9.99%).
ohcs Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerms
P5Y
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.25
CY2022Q2 ohcs Equity Method Investments Ownership Percentages
EquityMethodInvestmentsOwnershipPercentages
0.0999 pure
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
112200 usd
ohcs Amortization Of Debt Discount
AmortizationOfDebtDiscount
581411 usd
CY2021Q3 us-gaap Preferred Units Offering Costs
PreferredUnitsOfferingCosts
2000000 usd
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1
CY2021Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1160000 shares
CY2021Q4 ohcs Equity Method Investment Ownership Percentages
EquityMethodInvestmentOwnershipPercentages
700000.01 pure
CY2020Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
9998899 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5297500 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.74
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P9Y5M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1235000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P10Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6282500 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1623125 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.69
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y6M21D
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3886702 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7564796 usd
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
425000 usd
CY2021Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
425000 shares
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7751779 usd
CY2021 ohcs Increase In Optimus Healthcare Services Inc Ownership Interests In Craac From51 To9988
IncreaseInOptimusHealthcareServicesIncOwnershipInterestsInCRAACFrom51To9988
-274400 usd
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-8026179 usd
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
1155 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
16326 usd
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
16197 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1250935 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
734494 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
948 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
78165 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
666616 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
666616 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
666616 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.1172 pure
us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.0196 pure
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.0253 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0985 pure
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1054596 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
601151 usd
CY2022Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
80008 usd
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
68290 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
23940 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
51345 usd
CY2022Q2 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
30257 usd
CY2021Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
12553 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
27405 usd
CY2022Q2 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
2206 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
66930 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
78165 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
67878 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1172770 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
666616 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1172770 usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
666616 usd
CY2017Q4 srt Taxable Investment Securities Average Yield
TaxableInvestmentSecuritiesAverageYield
0.80 pure
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
193000 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4800000 usd
CY2022Q2 ohcs Forgiveness Of Ppp Loan
ForgivenessOfPPPLoan
usd
ohcs Forgiveness Of Ppp Loan
ForgivenessOfPPPLoan
usd
ohcs Forgiveness Of Ppp Loan
ForgivenessOfPPPLoan
usd
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 ohcs Gross Unrealized Gain
GrossUnrealizedGain
usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
ohcs Sharebased Compensation Arrangement By Weighted Average Remaining Term Options Exercised
SharebasedCompensationArrangementByWeightedAverageRemainingTermOptionsExercised
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001892025

Files In Submission

Name View Source Status
0001213900-22-052249-index-headers.html Edgar Link pending
0001213900-22-052249-index.html Edgar Link pending
0001213900-22-052249.txt Edgar Link pending
0001213900-22-052249-xbrl.zip Edgar Link pending
f10q0622ex31-1_optimus.htm Edgar Link pending
f10q0622ex31-2_optimus.htm Edgar Link pending
f10q0622ex32-1_optimus.htm Edgar Link pending
f10q0622ex32-2_optimus.htm Edgar Link pending
f10q0622_optimus.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ohcs-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
ohcs-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ohcs-20220630_def.xml Edgar Link unprocessable
ohcs-20220630_lab.xml Edgar Link unprocessable
ohcs-20220630_pre.xml Edgar Link unprocessable
f10q0622_optimus_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending